Before investigating whether, as observed in cancer cells [12], TFP impacts AKT/FOXO3 signaling, we first determined whether increased AKT/FOXO3 signaling is a feature of the hyperproliferative and apoptosis-resistant PAH-PASMCs. Here, AKT1 is linked to cancer.